person · Reporting owner
Murphy Patrick Michael
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | EVP, Chief Legal Officer | September 09, 2021 | September 14, 2021 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | CBO and CLO | August 07, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date September 09, 2021 · Filed September 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,254 |
Last balance in matching sequence
After 2021-09-09 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-09-09 · Sale · Disposed 975 · Balance 16,266 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Row 2 · 2021-09-09 · Sale · Disposed 12 · Balance 16,254 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
iRhythm Holdings, Inc.
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,699 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-07 · Grant · Acquired 13,589 · Balance 76,792 F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023. Row 2 · 2026-08-10 · Sale · Disposed 7,093 · Balance 69,699 F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.
F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 11, 2026 20:02 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 7,093 | $124.65 | $884,155.93 |
DisclosureSEC source: 0001692785-26-000009 · wk-form4_1786478535.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,699 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:02 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 13,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001692785-26-000009 · wk-form4_1786478535.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,792 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:34 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,139 | $128.45 | $146,301.25 |
DisclosureSEC source: 0001692785-26-000007 · wk-form4_1772580895.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,203 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:34 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,190 | $128.44 | $152,848.96 |
DisclosureSEC source: 0001692785-26-000007 · wk-form4_1772580895.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,342 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:34 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,028 | $128.44 | $260,473.68 |
DisclosureSEC source: 0001692785-26-000007 · wk-form4_1772580895.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,532 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 22:20 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 7,805 | $135.42 | $1,056,944.51 |
DisclosureSEC source: 0001692785-26-000002 · wk-form4_1772144442.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,536 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 7,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001692785-26-000005 · wk-form4_1772228307.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,560 F1 · shares: These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 22:20 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 15,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001692785-26-000002 · wk-form4_1772144442.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,341 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on February 27, 2023. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:35 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,478 | $184.83 | $458,008.74 |
DisclosureSEC source: 0001692785-25-000005 · wk-form4_1764797736.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,281 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:04 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 3,075 | $108.77 | $334,467.75 |
DisclosureSEC source: 0001388658-25-000065 · wk-form4_1741122251.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,759 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:04 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 12,513 | $108.93 | $1,363,041.09 |
DisclosureSEC source: 0001388658-25-000044 · wk-form4_1740690279.xml · nonDerivative · entry 5 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,834 F3 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:04 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 3,817 | $112.13 | $428,000.21 |
DisclosureSEC source: 0001388658-25-000044 · wk-form4_1740690279.xml · nonDerivative · entry 4 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,347 F3 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:04 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 8,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000044 · wk-form4_1740690279.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,164 F2 · shares: These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:04 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 23,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000044 · wk-form4_1740690279.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,188 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on February 15, 2022. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:04 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 7,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000044 · wk-form4_1740690279.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,630 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on February 15, 2022. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 20:45 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,492 | $85.89 | $214,037.88 |
DisclosureSEC source: 0001388658-24-000178 · wk-form4_1733258696.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,327 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:51 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,525 | $111.14 | $169,488.50 |
DisclosureSEC source: 0001388658-24-000058 · wk-form4_1709675462.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,437 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 00:19 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 7,615 | $121.96 | $928,725.40 |
DisclosureSEC source: 0001388658-24-000044 · wk-form4_1709338748.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,962 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:19 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 8,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-24-000044 · wk-form4_1709338748.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,577 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 28, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 22:17 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 17,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-24-000023 · wk-form4_1709245031.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,984 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance RSUs granted to the Reporting Person on February 15, 2022. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 00:15 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,686 | $88.82 | $149,750.52 |
DisclosureSEC source: 0001388658-23-000157 · wk-form4_1701908113.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CBO and CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,751 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple trades at prices ranging from $88.78 to $88.98 per share. The price reported above reflects the weighted average sale price. The Reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 19:09 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 571 | $117.23 | $66,938.33 |
DisclosureSEC source: 0001388658-23-000036 · wf-form4_167821616421468.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CLO & EVP RA/QA MrktAcs & Gov 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,437 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:17 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 9,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-23-000020 · wf-form4_167771262685504.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CLO & EVP RA/QA MrktAcs & Gov 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,008 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:37 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,704 | $106.78 | $181,953.12 |
DisclosureSEC source: 0001388658-22-000167 · wf-form4_167036260269254.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · CLO & EVP RA/QA MrktAcs & Gov 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,726 F1 · shares: These shares were sold to cover tax withholding and remittance obligations with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple trades at prices ranging from $106.39 to $106.78 per share. The price reported above reflects the weighted average sale price. The Reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 12 | $541.76 | $6,501.12 |
DisclosureSEC source: 0001093557-21-000215 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,254 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 975 | $541.36 | $527,826.00 |
DisclosureSEC source: 0001093557-21-000215 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,266 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:38 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $517.24 | $258,620.00 |
DisclosureSEC source: 0001093557-21-000199 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,241 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| July 26, 2021 Filed Jul 27, 2021 22:04 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $458.79 | $229,395.00 |
DisclosureSEC source: 0001093557-21-000183 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,741 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 23:05 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $431.49 | $215,745.00 |
DisclosureSEC source: 0001093557-21-000175 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,241 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:27 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $350.00 | $175,000.00 |
DisclosureSEC source: 0001093557-21-000156 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,741 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 22:27 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $415.83 | $207,915.00 |
DisclosureSEC source: 0001093557-21-000121 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,241 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| March 26, 2021 Filed Mar 30, 2021 21:45 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $350.00 | $175,000.00 |
DisclosureSEC source: 0001093557-21-000099 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,741 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:39 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,471 | $362.92 | $1,259,684.91 |
DisclosureSEC source: 0001093557-21-000075 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,241 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 00:28 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,634 | $0.00 | $5.63 |
DisclosureSEC source: 0001093557-21-000052 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,712 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $396.79 | $198,395.00 |
DisclosureSEC source: 0001093557-21-000036 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,078 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,803 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| January 27, 2021 Filed Jan 29, 2021 22:08 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $359.70 | $179,850.00 |
DisclosureSEC source: 0001093557-21-000014 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,578 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,803 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 01:58 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $355.39 | $177,695.00 |
DisclosureSEC source: 0001093557-20-000333 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,078 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,803 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:11 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 6,154 | $325.00 | $2,000,050.00 |
DisclosureSEC source: 0001093557-20-000322 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,578 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,803 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 22:58 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,003 | $398.30 | $399,496.91 |
DisclosureSEC source: 0001093557-20-000253 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,732 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,813 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 22:58 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 152 | $398.30 | $60,541.90 |
DisclosureSEC source: 0001093557-20-000253 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,735 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,813 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 22:58 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,289 | $398.30 | $513,411.28 |
DisclosureSEC source: 0001093557-20-000253 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,887 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,813 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:11 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $439.31 | $219,655.00 |
DisclosureSEC source: 0001093557-20-000222 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,176 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 21:13 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $435.80 | $217,900.00 |
DisclosureSEC source: 0001093557-20-000201 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,676 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 21:50 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $375.36 | $187,680.00 |
DisclosureSEC source: 0001093557-20-000181 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,176 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:16 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $404.05 | $202,025.00 |
DisclosureSEC source: 0001093557-20-000150 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,676 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:44 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $259.95 | $129,975.00 |
DisclosureSEC source: 0001093557-20-000125 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,176 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:07 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,921 | $265.43 | $1,040,735.35 |
DisclosureSEC source: 0001093557-20-000085 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · * 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,676 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:07 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 107 | $250.20 | $26,771.40 |
DisclosureSEC source: 0001093557-20-000085 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · * 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,597 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · price: This transaction was executed in multiple trades at prices ranging from $250.09 to $250.72. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:07 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 54 | $246.06 | $13,287.32 |
DisclosureSEC source: 0001093557-20-000085 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · * 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,704 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $246.00 to $246.0626. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 22:49 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $261.00 | $130,500.00 |
DisclosureSEC source: 0001093557-20-000056 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · * 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,758 F3 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.